We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$400B
AUM Growth
+$29.4B
Cap. Flow
+$10.8B
Cap. Flow %
2.7%
Top 10 Hldgs %
14.74%
Holding
7,051
New
207
Increased
2,867
Reduced
3,206
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 13.16%
2 Healthcare 9.53%
3 Financials 9.25%
4 Consumer Discretionary 7.98%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGIO icon
3401
Agios Pharmaceuticals
AGIO
$1.93B
$3.85M ﹤0.01%
49,949
-39,251
-44% -$3.16M
MIY icon
3402
BlackRock MuniYield Michigan Quality Fund
MIY
$353M
$3.85M ﹤0.01%
310,371
-167,225
-35% -$2.14M
TBPH icon
3403
Theravance Biopharma
TBPH
$877M
$3.85M ﹤0.01%
117,725
+15,919
+16% +$434K
ELD icon
3404
WisdomTree Emerging Markets Local Debt Fund
ELD
$143M
$3.84M ﹤0.01%
117,110
-12,050
-9% -$404K
CGEN icon
3405
Compugen
CGEN
$228M
$3.84M ﹤0.01%
998,173
+27,240
+3% +$95.3K
BHVN
3406
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.84M ﹤0.01%
102,354
-141,996
-58% -$5.22M
MYOK
3407
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$3.84M ﹤0.01%
58,880
-47,691
-45% -$2.8M
SE icon
3408
Sea Limited
SE
$69.5B
$3.84M ﹤0.01%
277,503
-60,061
-18% -$865K
PFC
3409
DELISTED
Premier Financial Corp. Common Stock
PFC
$3.82M ﹤0.01%
126,944
-16,086
-11% -$517K
ANGO icon
3410
AngioDynamics
ANGO
$649M
$3.82M ﹤0.01%
175,793
-31,583
-15% -$701K
JTA
3411
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
$3.82M ﹤0.01%
281,791
-7,861
-3% -$106K
PEJ icon
3412
Invesco Leisure and Entertainment ETF
PEJ
$308M
$3.82M ﹤0.01%
80,946
-76,707
-49% -$3.58M
SPAB icon
3413
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.94B
$3.82M ﹤0.01%
137,718
+5,996
+5% +$167K
RVNC
3414
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.81M ﹤0.01%
153,540
-29,219
-16% -$795K
VICI icon
3415
VICI Properties
VICI
$29.4B
$3.81M ﹤0.01%
176,428
+123,493
+233% +$2.56M
FOE
3416
DELISTED
Ferro Corporation
FOE
$3.81M ﹤0.01%
163,985
-197,804
-55% -$4.38M
BEL
3417
DELISTED
Belmond Ltd.
BEL
$3.81M ﹤0.01%
208,602
-95,221
-31% -$1.36M
GCC icon
3418
WisdomTree Enhanced Commodity Strategy Fund
GCC
$274M
$3.8M ﹤0.01%
210,569
-6,408
-3% -$116K
SWIR
3419
DELISTED
Sierra Wireless
SWIR
$3.79M ﹤0.01%
188,368
-39,842
-17% -$741K
CTT
3420
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$3.78M ﹤0.01%
331,028
-14,690
-4% -$181K
OCSI
3421
DELISTED
Oaktree Strategic Income Corporation
OCSI
$3.78M ﹤0.01%
436,597
-1,955
-0.4% -$16.8K
IFGL icon
3422
iShares International Developed Real Estate ETF
IFGL
$83.2M
$3.77M ﹤0.01%
131,480
-76,617
-37% -$2.23M
FG
3423
DELISTED
FGL Holdings Ordinary Shares
FG
$3.76M ﹤0.01%
420,517
+13,085
+3% +$117K
SPXX icon
3424
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$344M
$3.76M ﹤0.01%
222,523
+2,808
+1% +$47.6K
TCRT icon
3425
Alaunos Therapeutics
TCRT
$4.86M
$3.76M ﹤0.01%
7,836
-614
-7% -$263K

Similar funds

Morgan Stanley's Q3 2018 Portfolio in Review

As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,206 reduced and 165 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
  • Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
  • Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
  • Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
  • Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
  • Morgan Stanley opened 207 new positions and closed 165 in Q3 2018.
  • Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.

Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.